No Data
Earnings Troubles May Signal Larger Issues for Pulike Biological Engineering (SHSE:603566) Shareholders
pulike biological engineering,inc. (603566.SH): Cumulatively repurchased 1.2% of shares, company completes repurchase
Gelonghui, November 1st | Pulike Biological Engineering, Inc. (603566.SH) announced that on November 1, 2024, the company completed the repurchase, actually repurchasing 4,142,900 shares of the company's stock, accounting for 1.20% of the total share capital of the company. The highest repurchase price was 22.48 yuan/share, the lowest price was 11.66 yuan/share, and the average repurchase price was 14.56 yuan/share. The total amount paid was 60,328,181 yuan (excluding transaction costs).
Placo 2024 Third Quarter Report
pulike biological engineering,inc. (603566.SH): The net income for the first three quarters was 0.106 billion yuan, a year-on-year decrease of 40.67%.
Gelonghui October 29th | Pulike Biological Engineering,Inc. (603566.SH) announced that in the first three quarters of 2024, it achieved a revenue of 0.762 billion yuan, a decrease of 17.96% year-on-year; net income attributable to shareholders of the listed company was 0.106 billion yuan, a decrease of 40.67% year-on-year; basic earnings per share was 0.31 yuan.
Pulike Biological Engineering,Inc. (603566.SH) released its performance for the first three quarters, with a net income of 0.106 billion yuan, a year-on-year decrease of 40.67%.
Pulike Biological Engineering,Inc. (603566.SH) released the report for the first three quarters of 2024, during the reporting period the company achieved revenue of 7...
Pulike Biological Engineering, Inc. (SHSE:603566) Not Lagging Market On Growth Or Pricing
Benign Growth For Pulike Biological Engineering, Inc. (SHSE:603566) Underpins Stock's 27% PlummetNo Data
No Data
